baker bros advisors llc
-
Contact Information
baker bros advisors llc
667 MADISON AVE
NEW YORK NY 10065
Business Phone: 2123395600 13F Sector Allocation 03/31/2013
-
13F Activity for 03/31/2013
[1]Market Value: $4,952,093,295 [1]Prior Market Value: $3,782,410,513 New Purchases: 9 stocks Additional Purchases: 15 stocks Sold out of: 6 stocks Reduced holdings in: 12 stocks Top 10 Holdings %: 52.92% [1] - Market Value shown here may differ from what was reported on the actual 13F filing. The market value shown here includes only those securities that the Whalewisdom parsing engine successfully extracted. Value may also be rounded. Please refer to the actual 13F filing for verification. -
13F Holdings Summary
Top 13F Holdings on 03/31/2013 Stock % of Portfolio Pharmacyclics Inc. 17.54% SYNAGEVA BIOPHARMA 10.11% Genomic Health Inc. 7.1% Incyte Corporation 6.92% ViroPharma Inc. 4.28% Major new positions on 03/31/2013 Stock % of Portfolio Auxilium Pharmaceuticals Inc. (PRN) 2.2% Vertex Pharmaceuticals Incorporated 0.28% Ironwood Pharmaceuticals Inc. 0.25% QUESTCOR PHARMACEUTICALS, INC 0.22% STEMLINE THERAPEUTICS INC COM 0.11%
View All HoldingsMajor positions closed on 03/31/2013 Stock Prior % of Portfolio Vertex Pharmaceuticals Incorporated (PRN) 0.82% Spectrum Pharmaceuticals, Inc. 0.44% TRANZYME INC 0.06% DURATA THERAPEUTICS INC COM STK 0.03% Sequenom Inc. 0.0% -
Recent SEC Filings
Recent filings Form SC 13D/A 2013-05-17 Form 13F-HR 2013-05-15 Form SC 13G 2013-05-10 Form SC 13G/A 2013-03-11 Form SC 13D/A 2013-03-05